CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


20-January-2015
Cerilliant Introduces Certified Spiking Solutions® of the Nonbenzodiazepine Metabolite N-Desmethylzopiclone and its Stable-labeled Internal Standard N-Desmethylzopiclone-D4.

N-Desmethylzopiclone, D-111
100 µg/mL in Acetonitrile

A certified Snap-N-Spike® solution suitable as starting material in calibrators or controls in LC/MS or GC/MS n-desmethylzopiclone testing methods for applications such as urine drug testing, clinical toxicology, or forensic analysis. N-desmethylzopiclone is a primary, inactive metabolite of zopiclone in urine and blood. The parent drug, zopiclone, is a non-benzodiazepine hypnotic sold under the trade names Imovane® and Zimovane® and is used in the treatment of insomnia.

N-Desmethylzopiclone-D4, D-112
100 µg/mL in Acetonitrile

N-desmethylzopiclone is a primary, inactive metabolite of zopiclone. The parent drug, zopiclone, is a non-benzodiazepine hypnotic sold under the trade names Imovane® and Zimovane® and is used in the treatment of insomnia. This stable-labeled internal standard is suitable for quantitation of n-desmethylzopiclone in GC/MS or LC/MS testing methods for forensic analysis, urine drug testing, or clinical toxicology applications.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn